<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180113038347N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-11</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of the transitional care program from hospital to own home using the digital messaging application on self-efficacy, quality of life, cardiac symptoms, and medication adherence among patients undergoing coronary artery bypass graft surgery and caregiving burden in their family caregivers</public_title>
      <acronym></acronym>
      <scientific_title>The effect of the transitional care program from hospital to own home using the digital messaging application on self-efficacy, quality of life, cardiac symptoms, and medication adherence among patients undergoing coronary artery bypass graft surgery and caregiving burden in their family caregivers</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61178</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: A quadruple random block design will be used to assign samples to two groups of control and intervention randomly. Code A (for the intervention group) and Code B (for the control group) will be considered. Then the required random blocks and their sequence will be determined using the website: https://www. sealedenvelope.com.
Furthermore, sealed envelopes will be used for concealment. Thus, based on the sequence of randomly selected blocks, cards with the letters A (for the intervention group) or B (for the control group) indicating the assignment sequence will be placed inside the envelope. An envelope will then be opened for each participant in the study, respectively, and will be assigned to the control or intervention group based on the card inside the envelope.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Coronary artery bypass graft surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients in the intervention group will receive an intervention designed according to a person-centered care approach based on evidence-based practice and clinical knowledge. This program will include the following: (1) The researcher (nurse) will interview the patient and his / her family caregiver after the patient's hospitalization and will receive information about the patient's daily life before surgery, symptoms, impact of symptoms on daily life, assessment of social status, need for post-discharge support, daily life activities, and motivation/goals. Then, a post-discharge care plan for the patient based on the needs extracted in the previous stage will be developed with the cooperation of the patient himself, his / her family caregiver, and the researcher based on the literature. The designed program will also be approved by the patient's physician in the hospital. This program, by default, covers self-care activities, how to take medication, management of cardiac symptoms, diet, sexual and social activity, physical activity, control of risk factors, and time to see a doctor. It should be noted that this program is person-centered and will be based on the needs of patients and their family caregivers. In addition, before discharge, if needed, patients and their family caregivers are taught how to use WhatsApp and the functions associated with this application. General educational content will be created by the research team based on a review of the literature and includes additional training on heart disease, regular monitoring of blood pressure and heart rate, nutrition (general recommendations), and wound care; (2) Then, in the intervention group, the educational content related to the designed care program will be sent by the researcher in the form of text messages, video messages, and video and voice calls using the WhatsApp program to the patients and their family caregivers twice a week in the first 4 weeks of the intervention and then once a week in the second 4 weeks of the intervention (based on agreement with them). In addition, additional training on heart disease, regular control of blood pressure and heart rate, nutrition (general recommendations),  wound care (number of participants in each WhatsApp group for effective management by the researcher 5-8 people Will be) will be provided in a WhatsApp group. Moreover, twice a week patients will be asked about the presence of cardiac symptoms (angina, shortness of breath, fatigue, depression, sleep problems and pain at surgery, swelling of the legs, increased heart rate, anxiety, and anorexia) and If there are any symptoms, the necessary training will be provided in the form of a message according to the needs of patients and their family caregivers and the researcher will adjust the care program according to the needs of the patient at this stage. Furthermore, patients and their family caregivers will be free to share their concerns and questions with the researcher 24 hours a day, 7 days a week. At this stage, patients will be regularly encouraged to follow the care plan. Intervention 2: Control group: Patients and their family caregivers in the control group will receive routine care during discharge, including advice on cardiac symptom management, physical activity, medication, diet, and time to see a doctor based on face-to-face instruction and pamphlets by the ward nurse.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The data file will be provided to interested authors upon reasonable request after the publication of related articles.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Abbas Mardani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>VVali Asr St., above Vanak Square, Rashid Yasemi St</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996713883</zip>
        <telephone>+98 21 4365 1000</telephone>
        <email>abbasmardani30@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Abbas Mardani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>VVali Asr St., above Vanak Square, Rashid Yasemi St</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996713883</zip>
        <telephone>+98 21 4365 1000</telephone>
        <email>abbasmardani30@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria for patients: Age over 18 years
Performing coronary artery bypass graft (CABG) surgery for the first time in patients
No concomitant surgery during CABG surgery
Absence of respiratory diseases
Absence of drug and alcohol addiction
No history of seizures or mental health problems
No disturbance of consciousness or cognitive problems
Living with a family caregiver (spouse or children)
Have adequate health literacy
Having a smartphone
Ability to use WhatsApp
Conscious consent to participate in the study
Inclusion criteria for family caregivers: Age over 18 years
A close family member of the patient
Lack of a history of any mental health problems
Living with the patient
Have adequate health literacy
Having a smartphone
Ability to use WhatsApp
Ability to communicate effectively
The first experience of caring for a patient undergoing CABG surgery
Conscious consent to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Exclusion criteria for patients: Patient dissatisfaction to continue working with the researcher
Re-hospitalization of the patient during the research
Patient death during the intervention
Exclusion criteria for family caregivers:
Dissatisfaction to continue working with the researcher
Patient death during the intervention</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I25.7</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients in the intervention group will receive an intervention designed according to a person-centered care approach based on evidence-based practice and clinical knowledge. This program will include the following: (1) The researcher (nurse) will interview the patient and his / her family caregiver after the patient's hospitalization and will receive information about the patient's daily life before surgery, symptoms, impact of symptoms on daily life, assessment of social status, need for post-discharge support, daily life activities, and motivation/goals. Then, a post-discharge care plan for the patient based on the needs extracted in the previous stage will be developed with the cooperation of the patient himself, his / her family caregiver, and the researcher based on the literature. The designed program will also be approved by the patient's physician in the hospital. This program, by default, covers self-care activities, how to take medication, management of cardiac symptoms, diet, sexual and social activity, physical activity, control of risk factors, and time to see a doctor. It should be noted that this program is person-centered and will be based on the needs of patients and their family caregivers. In addition, before discharge, if needed, patients and their family caregivers are taught how to use WhatsApp and the functions associated with this application. General educational content will be created by the research team based on a review of the literature and includes additional training on heart disease, regular monitoring of blood pressure and heart rate, nutrition (general recommendations), and wound care; (2) Then, in the intervention group, the educational content related to the designed care program will be sent by the researcher in the form of text messages, video messages, and video and voice calls using the WhatsApp program to the patients and their family caregivers twice a week in the first 4 weeks of the intervention and then once a week in the second 4 weeks of the intervention (based on agreement with them). In addition, additional training on heart disease, regular control of blood pressure and heart rate, nutrition (general recommendations),  wound care (number of participants in each WhatsApp group for effective management by the researcher 5-8 people Will be) will be provided in a WhatsApp group. Moreover, twice a week patients will be asked about the presence of cardiac symptoms (angina, shortness of breath, fatigue, depression, sleep problems and pain at surgery, swelling of the legs, increased heart rate, anxiety, and anorexia) and If there are any symptoms, the necessary training will be provided in the form of a message according to the needs of patients and their family caregivers and the researcher will adjust the care program according to the needs of the patient at this stage. Furthermore, patients and their family caregivers will be free to share their concerns and questions with the researcher 24 hours a day, 7 days a week. At this stage, patients will be regularly encouraged to follow the care plan.</i_keyword>
      <i_keyword>Control group: Patients and their family caregivers in the control group will receive routine care during discharge, including advice on cardiac symptom management, physical activity, medication, diet, and time to see a doctor based on face-to-face instruction and pamphlets by the ward nurse.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Self- efficacy. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Cardiac Self-Efficacy Scale.</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: MacNew Heart Disease HRQL questionnaire.</prim_outcome>
      <prim_outcome>Cardiac symptoms. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Cardiac Symptom Scale.</prim_outcome>
      <prim_outcome>Medication adherance. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Morisky Medication Adherence Scale.</prim_outcome>
      <prim_outcome>Caregiving burden. Timepoint: Before the intervention, at the end of the intervention and two months after the intervention. Method of measurement: Caregiver Burden Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-01-02</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Tehran, Hemmat Highway next to Milad Tower, Iran University of Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
